tirzepatide cardiovascular outcomes trial results august 2025 60-Second Journal Club: The SUMMIT examined of treatment with in patients with heart failure with preserved ejection fraction and obesity. Read the full trial Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular

Most active players and API purchasers alike continue to source from China, making Chinese API supply a central variable in Indias GLP-1 economics regardless of how many domestic brands ultimately reach the market

Some research on bariatric surgery patients has documented changes in libido during periods of rapid weight loss, with subsequent improvement as weight stabilizes

Nausea Nausea is the most commonly reported tirzepatide side effect

But cellular repair does not make for a flashy Instagram post

In the long term if you are aware of your triggers, you can modify your diet to help you with managing your symptoms

May contain another active ingredient such as insulin instead of semaglutide